Madrigal Pharmaceuticals, Inc. Income Statement

Income Statement Dec2009 Dec2010 Dec2011 Mar2012 Dec2012 Dec2013 Dec2014 Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Revenue & cost
Revenue 144.25M14.80M7.58M1.00M0.15M-3.61M-1.21M0.35M0.20M0.10M0.27M-3.96M-12.71M180.13M
Cost of Revenue 6.23M
Gross Profit 144.25M14.80M7.58M1.00M0.15M-3.61M-1.21M0.35M0.20M0.10M0.27M-3.96M-12.71M173.90M
Operating items
Research & Development 51.05M40.25M41.46M49.41M71.86M68.20M2.43M15.93M24.39M25.39M72.32M184.81M205.16M245.44M272.35M236.72M
Selling, General & Administrative 12.65M11.45M11.55M11.68M15.70M15.75M0.81M9.29M7.67M15.29M22.65M21.86M37.32M48.13M108.15M435.06M
Restructuring Costs 1.24M
Other Operating Expenses 6.23M
Operating Expenses 64.94M51.70M53.02M61.09M87.56M83.95M3.23M25.22M32.06M40.68M94.97M206.67M242.48M293.57M380.50M678.01M
Operating Income 79.30M-36.90M-45.43M-60.94M-87.56M-83.95M-3.23M-25.22M-32.06M-40.68M-94.97M-206.67M-242.48M-293.57M-380.50M-497.88M
EBIT 79.30M-36.90M-45.43M-60.94M-87.56M-83.95M-3.23M-25.22M-32.06M-40.68M-94.97M-206.67M-242.48M-293.57M-380.50M-497.88M
Non-operating items
Interest & Investment Income -0.22M-0.57M-1.95M-1.85M-2.63M-2.21M0.05M0.56M7.67M11.02M4.33M0.36M2.19M19.58M46.65M
Other Non Operating Income 0.27M
Net income details
EBT 79.09M-37.47M-47.38M-62.79M-90.19M-86.16M-6.84M-26.39M-31.50M-33.01M-83.95M-202.34M-242.12M-295.35M-373.63M-465.89M
Profit After Tax 79.09M37.47M-47.38M-62.79M-90.19M-86.16M-6.84M-26.39M-31.15M-32.81M-83.95M-202.24M-241.85M-295.35M-373.63M-465.90M
Income from Continuing Operations 79.09M-37.47M-47.38M-62.79M-90.19M-86.16M-6.84M-26.39M-31.50M-33.01M-83.95M-202.34M-242.12M-295.35M-373.63M-465.89M
Consolidated Net Income 79.09M-37.47M-47.38M-62.79M-90.19M-86.16M-6.84M-26.39M-31.50M-33.01M-83.95M-202.34M-242.12M-295.35M-373.63M-465.89M
Income towards Parent Company 79.09M-37.47M-47.38M-62.79M-90.19M-86.16M-6.84M-26.39M-31.50M-33.01M-83.95M-202.34M-242.12M-295.35M-373.63M-465.89M
Net Income towards Common Stockholders 79.09M-37.47M-47.38M-62.79M-90.19M-86.16M-6.84M-26.39M-31.15M-33.01M-83.95M-202.34M-242.12M-295.35M-373.63M-465.89M
Additional items
EPS (Basic) 0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M
EPS (Weighted Average and Diluted) 0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M
Shares Outstanding (Weighted Average) 1.16M1.20M1.41M1.65M1.77M1.97M3.11M3.94M11.57M14.23M15.39M15.43M15.47M17.10M17.10M19.74M21.81M
Shares Outstanding (Diluted Average) 34.12M40.37M47.20M56.37M15.45M16.54M17.14M18.69M21.27M
EBITDA 79.30M-36.90M-45.43M-60.94M-87.56M-83.95M-3.23M-25.22M-32.06M-40.68M-94.97M-206.67M-242.48M-293.57M-380.50M-497.88M